Literature DB >> 20418170

Pain at presentation and survival in hepatocellular carcinoma.

Brian I Carr1, Lynette Pujol.   

Abstract

UNLABELLED: Pain is a common feature of most human cancers, including hepatocellular carcinoma (HCC). The reported frequency is quite variable, however, and the prognostic significance is not clear. In this report, we examine the incidence of pain in a large HCC database derived from unresectable patients whom we have treated and examine the prognostic and clinical correlates. We report that HCC patients with pain at presentation have a worse prognosis and adverse tumor characteristics. PERSPECTIVE: This article presents one of the first looks at correlates of pain and survival in HCC. Results of this study could inform future research and clinical investigations regarding the importance of pain at presentation in patients with HCC, which impacts qualify of life and survival.
Copyright © 2010 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20418170     DOI: 10.1016/j.jpain.2010.01.265

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  8 in total

1.  2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 2.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

3.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

4.  Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial.

Authors:  Pin Wu; Lu Zhu; Shi-Yu Zheng; Jun-Xiong Li; Meng-Die Wu; Wen-Jia Wang; Yu-Chao Hou; Jing Li; Huan-Gan Wu
Journal:  J Pain Res       Date:  2022-07-06       Impact factor: 2.832

Review 5.  Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review.

Authors:  Abdalla Aly; Sarah Ronnebaum; Dipen Patel; Yunes Doleh; Fernando Benavente
Journal:  Hepat Oncol       Date:  2020-07-21

6.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

Review 7.  Hepatocellular cancer pain: impact and management challenges.

Authors:  Nathaniel Christian-Miller; Catherine Frenette
Journal:  J Hepatocell Carcinoma       Date:  2018-07-19

Review 8.  Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma.

Authors:  Maaged Akiel; Devaraja Rajasekaran; Rachel Gredler; Ayesha Siddiq; Jyoti Srivastava; Chadia Robertson; Nidhi Himanshu Jariwala; Paul B Fisher; Devanand Sarkar
Journal:  J Hepatocell Carcinoma       Date:  2014-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.